EFEKTIVITAS METFORMIN TERHADAP PENURUNAN MORTALITAS PASIEN COVID-19 DENGAN KOMORBID DIABETES MELITUS TIPE 2 DI RSUP FATMAWATI TAHUN 2020 - 2021
COVID-19 (coronavirus disease 2019) is an infectious disease caused by the SARS-CoV-2 virus and was first identified in Wuhan, China. Compared to COVID-19 patients without comorbidity, COVID-19 patients with type 2 diabetes (T2DM) have a higher mortality rate. T2DM is a metabolic disease where the b...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
2023-05-23.
|
| Subjects: | |
| Online Access: | Link Metadata |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | repoupnvj_24499 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Yudivaniel Zihono, . |e author |
| 245 | 0 | 0 | |a EFEKTIVITAS METFORMIN TERHADAP PENURUNAN MORTALITAS PASIEN COVID-19 DENGAN KOMORBID DIABETES MELITUS TIPE 2 DI RSUP FATMAWATI TAHUN 2020 - 2021 |
| 260 | |c 2023-05-23. | ||
| 500 | |a http://repository.upnvj.ac.id/24499/1/ABSTRAK.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/12/ARTIKEL%20KI.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/2/AWAL.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/3/BAB%20I.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/4/BAB%20II.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/5/BAB%20III.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/6/BAB%20IV.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/7/BAB%20V.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/8/DAFTAR%20PUSTAKA.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/10/LAMPIRAN.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/14/HASIL%20PLAGIARISME.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/24499/11/RIWAYAT%20HIDUP.pdf | ||
| 520 | |a COVID-19 (coronavirus disease 2019) is an infectious disease caused by the SARS-CoV-2 virus and was first identified in Wuhan, China. Compared to COVID-19 patients without comorbidity, COVID-19 patients with type 2 diabetes (T2DM) have a higher mortality rate. T2DM is a metabolic disease where the body experience glucose elevation. T2DM patients usually receive metformin as first-line treatment. However, metformin efficacy in reducing patients' mortality rate still needs further analysis. This study's objective was to analyze metformin effectiveness in reducing COVID-19 patients with T2DM mortality rate in Fatmawati General Hospital in 2020 - 2021. An analytic observational design with a retrospective cohort approach was used. Samples were acquired from hospitalized COVID-19 patients with T2DM medical records in Fatmawati General Hospital in 2020 - 2021, gathered using a purposive sampling technique, and analyzed using Chi Square test. A total of 137 samples (56 received metformin, 81 did not receive metformin) were included in this study. Mortality in samples that received metformin (19,6%) was lower than those that did not (38,3%). Chi Square test showed a p-value<0,05 (p = 0,020) with a risk ratio<1,000 (risk ratio = 0,513), showing a relation between metformin treatment and lower mortality rate in COVID-19 patients with T2DM. This study concluded that metformin treatment was significantly related to a lower mortality rate in COVID-19 patients with T2DM in Fatmawati General Hospital. | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 690 | |a R Medicine (General) | ||
| 690 | |a RC Internal medicine | ||
| 690 | |a RM Therapeutics. Pharmacology | ||
| 655 | 7 | |a Thesis |2 local | |
| 655 | 7 | |a NonPeerReviewed |2 local | |
| 787 | 0 | |n http://repository.upnvj.ac.id/24499/ | |
| 787 | 0 | |n http://repository.upnvj.ac.id | |
| 856 | 4 | 1 | |u http://repository.upnvj.ac.id/24499/ |z Link Metadata |